Industry Satellite Symposia
Switch To Module
ESMO Congress 2022 - Conference Calendar
e-Posters
Industry Satellite Symposia
Everything
Everything
Session Title
Session Number
Presentation Title
Presentation Number
Author
Presenter
Chair
Filter By
Day
Select All
Deselect All
Fri, 09.09.2022
12
Sat, 10.09.2022
17
Sun, 11.09.2022
17
Mon, 12.09.2022
17
Room
Select All
Deselect All
7.1.D - Dijon Auditorium
8
7.2.E - Évry Auditorium
2
7.2.F - Fécamp Auditorium
6
7.3.G - Grenoble Auditorium
8
7.3.H - Honfleur Auditorium
7
7.3.O - Orléans Auditorium
6
7.3.Q - Quimper Auditorium
8
7.3.S - Strasbourg Auditorium
6
7.3.T - Toulouse Auditorium
6
7.3.U - Urval Auditorium
6
Session Type
Select All
Deselect All
EONS Industry Satellite Symposium
6
Industry Satellite Symposium
57
Presentation Type
Select All
Deselect All
Invited Speaker
1
Satellite Speaker
63
Presentation Topic
Select All
Deselect All
General interest
63
Cancel
Clear
Search
Advanced Search
Calendar view
All Sessions
All Presentations
Final Programme (PDF)
Industry Satellite Symposia
Browsing Over 63 Sessions
Sort By
Relevance
Upcoming First
Relevance
Session Number
Session Datetime
Incyte Biosciences International Sàrl - Targeting FGFR alterations in cholangiocarcinoma and other solid tumours: A new frontier in personalised medicine
(ID 97)
Time
13:00 - 14:30
MSD - Navigating through the rapidly evolving treatment landscape for GI Cancers - A Clinical & Patient Centric Approach towards implementing Immunotherapy
(ID 98)
Time
13:00 - 14:29
Pfizer Oncology - Journey through patient care: Long-term experience in advanced breast cancer
(ID 99)
Time
13:00 - 14:30
GSK - Avant-garde: Reframing the art of first-line maintenance therapy to optimise long-term outcomes in advanced ovarian cancer
(ID 101)
Time
13:00 - 14:30
Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
(ID 102)
Time
13:00 - 14:30
Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers
(ID 103)
Time
13:00 - 14:30
Merck Pfizer Alliance - New approaches to optimize treatment outcomes in advanced urothelial carcinoma
(ID 104)
Time
13:00 - 14:30
Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer
(ID 105)
Time
18:30 - 20:00
BeiGene Switzerland GmbH - Standard of Care is Not Enough! Talking Immunotherapy Clinical Trials in GI Cancers
(ID 106)
Time
18:30 - 19:40
Thermo Fisher Scientific - Connecting patients everywhere to precision oncology
(ID 107)
Time
18:30 - 20:00
PeerVoice - Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
(ID 108)
Time
18:30 - 19:55
Sanofi and Regeneron - Evolving Treatment Roadmap for Advanced and High-risk NMSC
(ID 109)
Time
18:30 - 20:00